964 related articles for article (PubMed ID: 20159642)
1. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
2. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.
Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A
Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773
[TBL] [Abstract][Full Text] [Related]
4. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular magnetic resonance in cardiac amyloidosis.
Maceira AM; Joshi J; Prasad SK; Moon JC; Perugini E; Harding I; Sheppard MN; Poole-Wilson PA; Hawkins PN; Pennell DJ
Circulation; 2005 Jan; 111(2):186-93. PubMed ID: 15630027
[TBL] [Abstract][Full Text] [Related]
6. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
[TBL] [Abstract][Full Text] [Related]
7. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
[TBL] [Abstract][Full Text] [Related]
8. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
[TBL] [Abstract][Full Text] [Related]
9. MR Imaging and Cardiac Amyloidosis Where to Go From Here?
Selvanayagam JB; Leong DP
JACC Cardiovasc Imaging; 2010 Feb; 3(2):165-7. PubMed ID: 20159643
[No Abstract] [Full Text] [Related]
10. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
[TBL] [Abstract][Full Text] [Related]
12. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
Mongeon FP; Jerosch-Herold M; Coelho-Filho OR; Blankstein R; Falk RH; Kwong RY
JACC Cardiovasc Imaging; 2012 Sep; 5(9):897-907. PubMed ID: 22974802
[TBL] [Abstract][Full Text] [Related]
13. Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis.
Aquaro GD; Pugliese NR; Perfetto F; Cappelli F; Barison A; Masci PG; Passino C; Emdin M
Int J Cardiovasc Imaging; 2014 Aug; 30(6):1105-15. PubMed ID: 24789582
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis.
Bhatti S; Watts E; Syed F; Vallurupalli S; Pandey T; Jambekar K; Mazur W; Hakeem A
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):970-7. PubMed ID: 27225804
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
[TBL] [Abstract][Full Text] [Related]
17. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
[TBL] [Abstract][Full Text] [Related]
18. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
[TBL] [Abstract][Full Text] [Related]
19. Cardiac amyloidosis: in search of the ideal diagnostic tool.
Mavrogeni SI; Vartela V; Ntalianis A; Vretou R; Ikonomidis I; Tselegkidou M; Paraskevaidis I; Markousis-Mavrogenis G; Noutsias M; Rigopoulos A; Kolovou G; Kastritis E
Herz; 2021 Apr; 46(Suppl 1):9-14. PubMed ID: 31796976
[TBL] [Abstract][Full Text] [Related]
20. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis.
Hoffmann R; Altiok E; Friedman Z; Becker M; Frick M
Am J Cardiol; 2014 Oct; 114(7):1083-8. PubMed ID: 25212549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
